Tag: medical

-- Patients treated with bezuclastinib showed a superior mean change in total symptom score at 24 weeks (-24.3 points vs. -15.4 points, -8.91 point placebo-adjusted difference; p=0.0002), compared to patients treated with placebo, establishing new benchmarks for placebo-adjusted and absolute symptomatic improvement for this patient population --

-- Bezuclastinib demonstrated a powerful effect on mast cell burden, with 87.4% of patients treated with bezuclastinib achieving at least 50% reduction in serum tryptase compared to 0% of patients treated with placebo --

PARIS, July 07, 2025 (GLOBE NEWSWIRE) --  PulseSight Therapeutics SAS, an ophthalmology biotech company developing disruptive non-viral vectorized therapies with minimally-invasive delivery technology, is pleased to announce that the first patient has been successfully dosed in its Phase I clinical trial (PST-611-CT1) aiming to assess safety and tolerability of its lead program, PST-611, in humans.

THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014)

THCA Vapes Dominate Premium Cannabis Market as Area 52 Named Best THCA Vape of 2025

New York City, NY, July 06, 2025 (GLOBE NEWSWIRE) --

As economic pressures continue to challenge U.S. households, many consumers with mid-tier credit scores are turning to personal loans for fair credit to manage unexpected expenses, consolidate debt, or fund necessary purchases. These loans provide structured repayment terms that may be more accessible than traditional financing while offering lower rates than high-cost subprime lending.